Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

ClinicalTrials.gov ID: NCT00003884

Public ClinicalTrials.gov record NCT00003884. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zoledronate (4 and 8 mg) Administered Intravenously as an Adjuvant to Anticancer Therapy to Patients With Any Cancer With Bone Metastases Other Than Breast Cancer, Multiple Myeloma or Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases. It is not yet known if zoledronate is more effective than no further therapy in relieving symptoms of bone metastases or preventing disease progression. PURPOSE: Randomized phase III trial to determine the effectiveness of zoledronate in treating patients who have solid tumors that have spread to the bone.

Study identification

NCT ID
NCT00003884
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis
Industry
Enrollment
600 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1998 (Type not available)
Primary completion
Jan 2001 (Actual)
Completion
Jan 2001 (Actual)
Last update posted
Feb 21, 2013

1998 – 2001

United States locations

U.S. sites
55
U.S. states
30
U.S. cities
51
Facility City State ZIP Site status
SORRA Research Center Birmingham Alabama 35203 —
Brookwood ACCC Birmingham Alabama 35209 —
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294 —
Highlands Oncology Group Springdale Arkansas 72764 —
Columbia South Valley Hospital Gilroy California 95020 —
Pacific Shores Medical Group Long Beach California 90813 —
Veterans Affairs Medical Center - West Los Angeles Los Angeles California 90073 —
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781 —
Southwest Cancer Care Poway California 92064 —
Cancer and Blood Institute of the Desert Rancho Mirage California 92270 —
Oncology Clinic, P.C. Colorado Springs Colorado 80909 —
Veterans Affairs Medical Center - Denver Denver Colorado 80220 —
Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C. District of Columbia 20007 —
Veterans Affairs Medical Center - Miami Miami Florida 33125 —
Oncology-Hematology Group of South Florida Miami Florida 33176 —
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 —
American Medical Research Institute, Inc. Atlanta Georgia 30338 —
Oncology Care Center - Belleville Belleville Illinois 62226 —
Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne Indiana 46885-5099 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Louisiana State University Medical Center Lafayette Louisiana 70502-4016 —
Ochsner Clinic New Orleans Louisiana 70121 —
Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana 71130-3932 —
Maine Center for Cancer Medicine and Blood Disorders Scarborough Maine 04074 —
Greater Baltimore Medical Center and Cancer Center Baltimore Maryland 21204 —
New England Medical Center Hospital Boston Massachusetts 02111 —
New England Hematology/Oncology Associates, P.C. Wellesley Massachusetts 02181 —
Henry Ford Hospital Detroit Michigan 48202 —
Spectrum Health and DeVos Children's Hospital Grand Rapids Michigan 49503 —
St. Mary's/Duluth Clinic Health System Duluth Minnesota 55805 —
Hubert H. Humphrey Cancer Center Robbinsdale Minnesota 55422 —
Kansas City Internal Medicine Kansas City Missouri 64132 —
Missouri Baptist Cancer Center St Louis Missouri 63131 —
Veterans Affairs Medical Center - Reno Reno Nevada 89520 —
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07018-1095 —
Brookdale University Hospital and Medical Center Brooklyn New York 11212 —
North Shore University Hospital Manhasset New York 11030 —
New York Presbyterian Hospital - Cornell Campus New York New York 10021 —
University of Rochester Cancer Center Rochester New York 14642 —
Albert Einstein Comprehensive Cancer Center The Bronx New York 10461 —
Raleigh Internal Medicine Raleigh North Carolina 27609 —
Cleveland Clinic Cancer Center Cleveland Ohio 44195 —
Hematology Oncology Consultants Inc Columbus Ohio 43235 —
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73190 —
Regional Cancer Center - Erie Erie Pennsylvania 16505 —
Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15213 —
Palmetto Hematology/Oncology Associates Spartanburg South Carolina 29303 —
Dial Research Associates Brentwood Tennessee 37027 —
Methodist Hospitals of Memphis Memphis Tennessee 38103 —
Cancer Specialist of South Texas. P.A. Corpus Christi Texas 78412 —
University of Texas Health Center at Tyler Tyler Texas 75710 —
Huntsman Cancer Institute Salt Lake City Utah 84132 —
Danville Hematology and Oncology, Inc. Danville Virginia 24541 —
Swedish Cancer Institute Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003884, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 21, 2013 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00003884 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →